Business
CEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions of people suffering around the...
This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical...
Top 10 Psychedelic stocks to own according to PSIL ETF (DO I AGREE?) What’s up Psychedelic Investors!?! Today we are...
Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies....
This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility,...
PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier...
BREAKING NEWS: Advisor Share Psychedelic Medicines ETF, PSIL, is going live THIS WEEK!!!! Investing in ETFs can be a good...
"HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did...
MindMed's Patent STRATEGY & WHY Haven't We Covered It YET? (MMED/ MNMD) Patents and IP are important because it allows...
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat...